We hoped that our city might be “the last place this ever happened.”
Before May 14, 2022, if you mentioned Buffalo, NY, my mind would have taken me back to the city I knew in the 1960s. I grew up there. I was a kid from the ‘hood whose grandmother instilled messages about living a life based on grace and humility from day one. I was a Head Start kid surrounded by people who believed in the power of providing possibility. I was a kid from the poor, Black neighborhood that bordered the poorer, Black neighborhood, but I was rich in the experiences that earned me an acceptance letter to the University of Notre Dame where I got the foundation I needed to go to medical school. It is Buffalo, however, where I got the foundation I needed for life.
Tuesday began a typical day in May in South Texas for me as executive director of the Mays Cancer Center. It was a lovely sunny day for late spring, and at our center we were focused, as we are each day, on the core mission we have had for almost 50 years—to decrease the burden of cancer in San Antonio, South Texas and beyond.
Stand Up To Cancer established two teams, the SU2C Lung Cancer Health Equity Research Team and SU2C Catalyst, that aim to improve cancer health equity.
AmerisourceBergen launched Clinical Trial Navigator, a solution suite that supports biopharmaceutical clinical trial recruitment within community-based specialty practices.
The Union for International Cancer Control and multiple partners are establishing the Access to Oncology Medicines Coalition, a global partnership to increase access to quality-assured essential cancer medicines in low- and lower-middle-income countries, and to help countries develop the capacity for their proper use.
ASCO and the Association of Community Cancer Centers jointly released recommendations addressing the lack of equity, diversity, and inclusion in cancer clinical trials.
From 1999 to 2019, rates of cancer deaths declined steadily among Black people in the United States. Nevertheless, in 2019, Black people still had considerably higher rates of cancer death than people in other racial and ethnic groups, according to a large epidemiologic study led by NCI researchers.
The COVID-19 pandemic has demonstrated that real-world data is an indispensable tool healthcare professionals should use to rapidly respond to emerging gaps in care delivery.
In a panel discussion this week, five leaders in oncology proposed an action plan for tackling cancer health disparities and enhancing health equity.
